Bailard’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-495
Closed -$234K 803
2026
Q1
$234K Sell
495
-9
-2% -$4.53K 0.01% 679
2025
Q4
$235K Sell
504
-7
-1% -$3.25K 0.01% 664
2025
Q3
$218K Buy
+511
New +$198K ﹤0.01% 713
2024
Q4
Sell
-508
Closed -$206K 771
2024
Q3
$206K Buy
+508
New +$186K 0.01% 711
2020
Q1
Sell
-2,056
Closed -$304K 500
2019
Q4
$304K Sell
2,056
-13,250
-87% -$1.78M 0.02% 407
2019
Q3
$1.84M Sell
15,306
-288
-2% -$37.2K 0.11% 162
2019
Q2
$2.11M Sell
15,594
-1,051
-6% -$133K 0.13% 152
2019
Q1
$2.17M Buy
+16,645
New +$2.24M 0.13% 152

Other funds holding HCA

Bailard's HCA Position: Q2 2026 in Review

Bailard sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 495 shares — an estimated $234K sold.

Bailard first reported a position in HCA in Q1 2019 and held it in 8 quarters. The position peaked at $2.17M in Q1 2019. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Bailard reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Bailard sold 495 HCA Healthcare shares in Q2 2026, an estimated $234K.
  • Bailard first reported a position in HCA Healthcare in Q1 2019 and held it in 8 quarters.
  • Bailard's HCA Healthcare position peaked at $2.17M in Q1 2019.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.